WELT:XETRA:XETRA-Amundi S&P Global Industrials ESG UCITS ETF DR EUR Inc (EUR)

ETF | Others |

Last Closing

USD 12.98

Change

-0.09 (-0.67)%

Market Cap

USD 0.25B

Volume

2.03K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.10 (-0.20%)

USD 509.68B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.12%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.01 (-0.04%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.01 (+0.02%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.13 (-0.53%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.19 (+0.43%)

USD 101.50B
8R80:XETRA Amundi Index Solutions - Amund..

+0.12 (+0.08%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.07 (-0.13%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.98 (+0.74%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.01 (-0.05%)

USD 79.79B

ETFs Containing WELT:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.52% 55% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.52% 55% F 56% F
Trailing 12 Months  
Capital Gain 13.11% 68% D+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.11% 67% D+ 68% D+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.54% 59% D- 58% F
Dividend Return 6.54% 58% F 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.39% 64% D 72% C
Risk Adjusted Return 69.71% 80% B- 82% B
Market Capitalization 0.25B 52% F 46% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike